Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.91B |
| 2 |
United Parcel Service
UPS
|
+$1.86B |
| 3 |
Chevron
CVX
|
+$1.72B |
| 4 |
Blackstone
BX
|
+$904M |
| 5 |
Ford
F
|
+$722M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.64B |
| 2 |
Prudential Financial
PRU
|
+$553M |
| 3 |
Genuine Parts
GPC
|
+$543M |
| 4 |
Cummins
CMI
|
+$538M |
| 5 |
Hartford Financial Services
HIG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.33% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Information Services Group
III
$205M
| $497K | ﹤0.01% |
97,645
+1,011
| +1% | +$5.19K |
|
|
JBIO
2952
Jade Biosciences
JBIO
$1.17B
| $497K | ﹤0.01% |
704
| – | – |
|
2953
Taboola.com
TBLA
$1.42B
| $496K | ﹤0.01% |
+182,416
| New | +$615K |
|
2954
Village Super Market
VLGEA
$650M
| $496K | ﹤0.01% |
21,671
-1,408
| -6% | -$32.3K |
|
|
HYZN
2955
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $495K | ﹤0.01% |
12,152
+212
| +2% | +$15.8K |
|
|
BGRY
2956
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $494K | ﹤0.01% |
357,890
+40,292
| +13% | +$48K |
|
2957
Banco Santander
SAN
$206B
| $492K | ﹤0.01% |
133,398
+62,826
| +89% | +$224K |
|
|
BCOV
2958
DELISTED
Brightcove, Inc.
BCOV
| $491K | ﹤0.01% |
110,396
+2,067
| +2% | +$11.5K |
|
2959
Tango Therapeutics
TNGX
$4.43B
| $489K | ﹤0.01% |
123,857
| – | – |
|
2960
Parke Bancorp
PKBK
$400M
| $488K | ﹤0.01% |
27,467
| – | – |
|
2961
Red Violet
RDVT
$968M
| $485K | ﹤0.01% |
27,540
| – | – |
|
2962
Valhi
VHI
$380M
| $482K | ﹤0.01% |
27,708
-13,284
| -32% | -$300K |
|
2963
Vanguard S&P 500 ETF
VOO
$993B
| $482K | ﹤0.01% |
+1,281
| New | +$470K |
|
2964
GSK
GSK
$103B
| $481K | ﹤0.01% |
13,522
+5,368
| +66% | +$188K |
|
2965
Veritone
VERI
$103M
| $480K | ﹤0.01% |
82,358
| – | – |
|
2966
Vera Therapeutics
VERA
$2.31B
| $477K | ﹤0.01% |
61,419
+22,560
| +58% | +$174K |
|
2967
iShares Core S&P Total US Stock Market ETF
ITOT
$95.7B
| $476K | ﹤0.01% |
5,256
+1,379
| +36% | +$122K |
|
2968
Ring Energy
REI
$320M
| $476K | ﹤0.01% |
250,486
| – | – |
|
2969
Invivyd
IVVD
$163M
| $476K | ﹤0.01% |
396,465
-4,053
| -1% | -$7.4K |
|
|
ARIS
2970
DELISTED
Aris Water Solutions
ARIS
| $472K | ﹤0.01% |
60,580
| – | – |
|
2971
PepGen
PEPG
$130M
| $471K | ﹤0.01% |
38,489
+2,253
| +6% | +$35.3K |
|
2972
Adicet Bio
ACET
$86.4M
| $468K | ﹤0.01% |
5,073
| – | – |
|
2973
Tilly's
TLYS
$121M
| $466K | ﹤0.01% |
60,458
| – | – |
|
|
NETI
2974
DELISTED
Eneti Inc.
NETI
| $464K | ﹤0.01% |
49,627
| – | – |
|
2975
UBS Group
UBS
$173B
| $462K | ﹤0.01% |
21,645
+5,940
| +38% | +$124K |
|
Similar funds
Charles Schwab's Q1 2023 Portfolio in Review
As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
- Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
- Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
- Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
- Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
- Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
- Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.
Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.